CFACT Staff Publications: G. Edward Miller

You Are Here: AHRQ Home > About AHRQ > Offices and Centers > CFACT Publications by Staff > G. Edward Miller

Center for Financing, Access, and Cost Trends (CFACT): Publications by Staff

G. Edward Miller

Authors: Hill S, Miller GE, Sing M
Title: Adults with diagnosed and untreated diabetes: Who are they? How can we reach them?
Publication: Journal of Health Care for the Poor and Underserved; 22(4):1221-38
Date: November 2011
Abstract: Available on Pub Med®.

Authors: Miller GE, Sarpong E
Title: Trends in the pharmaceutical treatment of children's asthma, 1997-1998 to 2007-2008
Publication: MEPS Research Findings No. 31. Available on the MEPS Web site.
Date: September 2011
Abstract: Among children with reported treatment for asthma, trends are examined in the use and expenditures of three major types of medications: controllers, relievers, and oral corticosteroids. Expenditures for controllers accounted for about 90 percent of increased spending. Differences in controller use persisted in 2007-2008, as minority, publicly insured and poor and low income children were less likely than others to use these medications and were more likely to use relievers only.

Authors: Sarpong E, Miller GE
Title: Changes in children's use and expenditures for asthma medications, United States, 1997-1998 to 2007-2008
Publication: MEPS Statistical Brief No. 341. Available on the MEPS Web site.
Date: September 2011
Abstract: This Statistical Brief examines changes in medication use and expenditures among children with reported treatment for asthma from 1997-1998 to 2007-2008. Overall, the average annual proportion of children with reported treatment for asthma in the U.S. increased from 4.7 percent in 1997-1998 to 6.1 percent in 2007-2008.

Authors: Sarpong E, Miller GE
Title: Asthma medication use among children with reported treatment for asthma, United States, 2007-2008
Publication: MEPS Statistical Brief No. 340. Available on the MEPS Web site.
Date: September 2011
Abstract: This Statistical Brief examines controller and reliever use across groups of children by race/ethnicity, sex, income, health insurance status, and Census region data from 2007 and 2008.

Authors: Carroll W, Miller GE
Title: Health insurance status of full-time workers by demographic and employer characteristics, 2008
Publication: MEPS Statistical Brief No. 317. Available on the MEPS Web site.
Date: March 2011
Abstract: This Statistical Brief examines the health insurance status of non-elderly adults who worked full time for the full year. Estimates of the health insurance status of full-time non-elderly workers in the U.S. civilian noninstitutionalized population are essential to policymakers and others concerned with the availability of insurance coverage for workers and their families.

Authors: Sarpong E, Miller GE
Title: Trends in the pharmaceutical treatment of diabetes, 1997 to 2007
Publication: MEPS Research Findings No. 30. Available on the MEPS Web site.
Date: September 2010
Abstract: In addition to investigating aggregate trends in drug utilization among persons reporting treatment for diabetes, we examine anti-diabetic medication use in subgroups of this population. In particular, we examine trends within and differences across groups defined by age, race/ethnicity, health insurance, income, and education. Results presented for selected population characteristics and drug expenditures are estimated using pooled data for 1997-1998 and 2006-2007.

Authors: Sarpong E, Miller GE
Title: Trends in pharmaceutical treatment of diabetes: A comparison of utilization and expenditures, 1997 to 2007
Publication: MEPS Statistical Brief No. 293. Available on the MEPS Web site.
Date: September 2010
Abstract: In this Statistical Brief, we present estimates based on data from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) on trends from 1997 to 2007 in anti-diabetic medication use and expenditures in the U.S. civilian noninstitutionalized population. The sample is composed of persons with diagnosed diabetes who reported treatment for diabetes during the year. Between 1997 and 2007, the total number of persons with diabetes who reported using oral anti-diabetic medications more than doubled, from 5.9 million to 14.6 million. In 1997, 3.7 million persons who reported treatment for diabetes were using insulin compared with 4.6 million in 2007.

Authors: Kirby J, Hudson J, Miller, GE
Title: Explaining racial and ethnic differences in antidepressant use among adolescents
Publication: Medical Care Research and Review 67(3):342-63.
Date: June 2010
Abstract: Available on PubMed.

Authors: Hill S, Miller GE
Title: Health expenditure estimation and functional form: Applications of the generalized gamma and extended estimating equations models
Publication: Health Economics 19(5):608-27
Date: May 2010
Abstract: Available on PubMed®.

Authors: Carroll W, Miller GE
Title: Health insurance status of low income, non-elderly persons by demographic characteristics, 2007
Publication: MEPS Statistical Brief No. 281. Available on the MEPS Web site.
Date: March 2010
Abstract: In 2007, there were 77.8 million persons under age 65 living in families with incomes below 200 percent of the federal poverty threshold. More than one-quarter (25.9 percent) of persons living in these non-elderly low income families were uninsured for the entire year, less than one-third (32.5 percent) had any private insurance coverage during the year, and 41.6 percent had public only coverage.

Authors: Aspinall S, Banthin J, Good C, Miller GE, Cunningham F
Title: VA pharmacy users: How they differ from other veterans
Publication: The American Journal of Managed Care 15 (10):701-8
Date: October 2009
Abstract: Available on PubMed®.

Authors: Carroll W, Miller GE
Title: Full-time poor and low income workers: Demographic characteristics and trends in health insurance coverage, 1996-1997 to 2005-06
Publication: MEPS Chartbook No. 18. Available on the MEPS Web site.
Date: June 2009
Abstract: This Chartbook provides an overview of the income and employment characteristics for the U.S. civilian noninstitutionalized adult population, and compares the health insurance status of low, middle, and high income full-time workers. It presents information on the demographic characteristics, health status, job characteristics, and health insurance status of full-time low income workers.

Authors: Miller GE, Carroll W
Title: Health insurance status of full time workers by demographic and employer characteristics, 2006
Publication: MEPS Statistical Brief No. 234. Available on the MEPS Web site
Date: January 2009
Abstract: In 2006, 85.4 percent of the 97.7 million non-elderly full-time full year workers in the U.S. had private insurance at some point during the year. Among these privately insured workers, 96.9 percent had employer-sponsored coverage and 3.1 percent had individually purchased private insurance only.

Authors: Hudson J, Miller G, Kirby J
Title: Explaining racial and ethnic differences in children's use of stimulant medications
Publication: Med Care 45(11):1068-75
Date: 2007
Abstract: Available on PubMed®

Authors: Miller, GE, Zodet M
Title: Trends in the pharmaceutical treatment of hypertension, 1997-2003
Publication: MEPS Research Findings No. 25. Available on the MEPS Web site
Date: July 2006
Abstract: Using nationally representative data from the MEPS-HC, this report examines trends in the use of five classes of anti-hypertensive drugs (diuretics, beta blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers) from 1997 through 2003. The sample for the study is comprised of U.S. adults, ages 18 and older, who reported treatment for hypertension. In addition to aggregate trends, the report also examines trends within and differences across subgroups of the population.

Authors: Banthin J, Miller GE
Title: Trends in prescription drug expenditures by Medicaid enrollees
Publication: Med Care 44(5 Suppl):127-35
Date: May 2006
Abstract: Available on PubMed®

Authors: Miller GE, Hudson J
Title: Children and antibiotics: Analysis of reduced use, 1996-2001
Publication: Med Care 44(5 Suppl):136-44
Date: May 2006
Abstract: Available on PubMed®

Authors: Doshi A, Miller GE
Title: Trends in the use of diuretics to treat hypertension, 1997 and 2003
Publication: MEPS Statistical Brief No. 120. Available on the MEPS Web site
Date: March 2006
Abstract: This statistical brief presents estimates based on data from the MEPS-HC on trends from 1997 to 2003 in diuretic use among adults ages 18 and older in the U.S. civilian noninstitutionalized population, by age, sex, race/ethnicity, income, insurance status, education, and health status.

Authors: Miller GE, Doshi A
Title: Diuretic use in the treatment of hypertension, by selected population characteristics, 2003
Publication: MEPS Statistical Brief No. 119. Available on the MEPS Web site
Date: March 2006
Abstract: This statistical brief presents estimates based on data from the 2003 MEPS-HC on diuretic use among adults ages 18 and older in the U.S. civilian noninstitutionalized population, by age, sex, race/ethnicity, income, insurance status, education, and health status.

Authors: Machlin S, Miller E
Title: Health service use and expenses for migraines and other headaches
Publication: MEPS Statistical Brief No. 115. Available on the MEPS Web site
Date: February 2006
Abstract: This statistical brief presents estimates based on data from the MEPS-HC on health care use and expenditures to treat headaches among adults age 18 and over in the U.S. civilian noninstitutionalized population. Average annual estimates for the period from 2002–03 are shown for two categories of headaches: migraines and other headaches (facial pain, nonspecific reported pain in head, and tension headaches) as well as by age and sex.

Authors: Miller GE, Moeller J, Stafford R
Title: New cardiovascular drugs: Patterns of use and association with non-drug health expenditures
Publication: Inquiry 42(4):397-412
Date: Winter 2005/2006
Abstract: Available on PubMed®

Authors: Miller GE, Stagnitti M
Title: Trends in statin use in the civilian noninstitutionalized Medicare population, 1997 and 2002
Publication: MEPS Statistical Brief No. 97. Available on the MEPS Web site
Date: September 2005
Abstract: This statistical brief presents data from MEPS-HC on statin use in the U.S. civilian noninstitutionalized Medicare population in 1997 and 2002. Estimates are presented for subgroups of the Medicare population defined by age, race/ethnicity, sex, poverty status, insurance status, and health status.

Authors: Miller GE, Stagnitti M
Title: Statin use in the civilian noninstitutionalized Medicare population in 2002
Publication: MEPS Statistical Brief No. 96. Available on the MEPS Web site
Date: September 2005
Abstract: This statistical brief presents data from the MEPS-HC on statin use in the civilian noninstitutionalized Medicare population in 2002. Estimates are presented for subgroups of this population defined by sex, age, race/ethnicity, insurance status, poverty status, and health status.

Authors: Miller GE, Carroll WA
Title: Trends in children's antibiotic use: 1996 to 2001
Publication: MEPS Research Findings No. 23. Available on the MEPS Web site
Date: March 2005
Abstract: This report uses nationally representative data from MEPS to examine antibiotic use by U.S. children for the years 1996-2001. Trends in antibiotic use for subgroups of children defined by age, race/ethnicity, sex, income, insurance status, health status, and geography are also examined.

Authors: Correa-de-Araujo R, Miller GE, Banthin J, Trinh Y
Title: Gender differences in drug use and expenditures in a privately insured population of older adults
Publication: J Womens Health 14(1):73-81
Date: Jan-Feb 2005
Abstract: Available on PubMed®

Authors: Moeller J, Miller GE, Banthin J
Title: Looking inside the nation's medicine cabinet: Trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001
Publication: Health Affairs 23(5):217-25
Date: Sep-Oct 2004
Abstract: Available on PubMed®

Authors: Carroll W, Miller E
Title: Trends in antibiotic use among U.S. children aged 0 to 4 years, 1996-2000
Publication: MEPS Statistical Brief No. 35. Available on the MEPS Web site
Date: 2003
Abstract: This statistical brief presents data from the MEPS-HC on antibiotic drug use by U.S. children aged 0 to 4 years for the calendar years 1996 through 2000. The definition of antibiotics includes all major classes of oral antibiotics but excludes topical antibiotics. The estimates presented come from the MEPS Full-Year Files for 1996-2000 and the MEPS Prescribed Medicines Files for the same period.

Authors: Stagnitti M, Miller GE, Moeller J
Title: Outpatient prescription drug expenses, 1999
Publication: MEPS Chartbook No. 12. AHRQ Pub. No. 04-0001. Available on the MEPS Web site
Date: 2003
Abstract: This chartbook presents data from the 1999 MEPS on spending for outpatient prescription medicines for the U.S. civilian noninstitutionalized population. This chartbook is organized into three sections. Section 1 presents a summary of overall outpatient prescription medicine expenses and payments. Section 2 contains outpatient prescription medicine expenses and payments by various population groups. Section 3 contains expenses on outpatient prescription drugs by therapeutic class.

Authors: Miller GE, Moeller J
Title: Outpatient prescription drug prices and insurance coverage: An analysis by therapeutic drug class and user characteristics from the 1996 Medical Expenditure Panel Survey
Publication: Investing in Health: The Social and Economic Benefits of Health Care Innovation 14:23-57
Date: 2001
Abstract: The authors used a data set that contains information on a nationally representative sample of drug purchases in 1996 to investigate the relationship between the type of insurance individuals have for prescription drugs—private insurance, Medicaid, or uninsured—and both the type of drugs they purchase and the prices they pay for drugs. The authors found that uninsured persons use more generic drugs than privately insured persons but fewer generic drugs than Medicaid recipients. To compare retail drug prices across insurance types, the authors used standardized prices—the retail unit price of each drug relative to a benchmark price. We find that uninsured individuals pay standardized prices that are, on average, 16.5 percent higher than the standardized prices paid by privately insured persons, and 8.4 percent higher than the standardized prices paid by Medicaid recipients.

Previous Section CFACT Author Index Next Section